Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 27:12:958210.
doi: 10.3389/fcimb.2022.958210. eCollection 2022.

Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess

Affiliations
Review

Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess

Huanna Tang et al. Front Cell Infect Microbiol. .

Abstract

A tubo-ovarian abscess (TOA) is a common type of inflammatory lump in clinical practice. TOA is an important, life-threatening disease, and it has become more common in recent years, posing a major health risk to women. Broad-spectrum antimicrobial agents are necessary to cover the most likely pathogens because the pathogens that cause TOA are polymicrobial. However, the response rate of antibiotic treatment is about 70%, whereas one-third of patients have poor clinical consequences and they require drainage or surgery. Rising antimicrobial resistance serves as a significant reason for the unsatisfactory medical outcomes. It is important to study the antibiotic resistance mechanism of TOA pathogens in solving the problems of multi-drug resistant strains. This paper focuses on the most common pathogenic bacteria isolated from TOA specimens and discusses the emerging trends and epidemiology of resistant Escherichia coli, Bacteroides fragilis, and gram-positive anaerobic cocci. Besides that, new methods that aim to solve the antibiotic resistance of related pathogens are discussed, such as CRISPR, nanoparticles, bacteriophages, antimicrobial peptides, and pathogen-specific monoclonal antibodies. Through this review, we hope to reveal the current situation of antibiotic resistance of common TOA pathogens, relevant mechanisms, and possible antibacterial strategies, providing references for the clinical treatment of drug-resistant pathogens.

Keywords: Bacteroides fragilis; Escherichia coli; antibiotic resistance; antibiotics; gram-positive anaerobic cocci; tubo-ovarian abscess.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Akselim B., Karasin S. S., Demirci A., Ustunyurt E. (2021). Can Antibiotic Treatment Failure in Tubo-Ovarian Abscess be Predictable? Eur. J. Obstet. Gynecol. Reprod. Biol. 258, 253–257. doi: 10.1016/j.ejogrb.2021.01.011 - DOI - PubMed
    1. Alauzet C., Lozniewski A., Marchandin H. (2019). Metronidazole Resistance and Nim Genes in Anaerobes: A Review. Anaerobe 55, 40–53. doi: 10.1016/j.anaerobe.2018.10.004 - DOI - PubMed
    1. Aliabadi S., Anyanwu P., Beech E., Jauneikaite E., Wilson P., Hope R., et al. . (2021). Effect of Antibiotic Stewardship Interventions in Primary Care on Antimicrobial Resistance of Escherichia Coli Bacteraemia in England, (2013-18): A Quasi-Experimental, Ecological, Data Linkage Study. Lancet Infect. Dis. 21 (12), 1689–1700. doi: 10.1016/S1473-3099(21)00069-4 - DOI - PMC - PubMed
    1. Amani J., Barjini K. A., Moghaddam M. M., Asadi A. (2015). In Vitro Synergistic Effect of the CM11 Antimicrobial Peptide in Combination With Common Antibiotics Against Clinical Isolates of Six Species of Multidrug-Resistant Pathogenic Bacteria. Protein Pept. Lett. 22 (10), 940–951. doi: 10.2174/0929866522666150728115439 - DOI - PubMed
    1. Ayala J., Quesada A., Vadillo S., Criado J., Piriz S. (2005). Penicillin-Binding Proteins of Bacteroides Fragilis and Their Role in the Resistance to Imipenem of Clinical Isolates. J. Med. Microbiol. 54 (Pt 11), 1055–1064. doi: 10.1099/jmm.0.45930-0 - DOI - PubMed

Substances